The World Health Organization (WHO) updated its evidence-based guideline on chronic HCV infection in July 2018. Although the WHO guideline is primarily targeted toward policymakers in low- and middle-income countries, recommendations are relevant to the United States, where equity and resource allocation issues are also important considerations. We discuss implications of the WHO recommendations for clinicians and patients in the United States.